A personalized mRNA Vaccine provides ‘real hope’ for melanoma patients | The Optimist Daily
www.optimistdaily.com
Redefining cancer therapy: a closer look at the cutting-edge mRNA vaccine trials for melanoma.

I missed this before, but apparently we’re now nearly a year into Merck and Moderna’s Phase-3 trials of a novel mRNA vaccine (mRNA-4157) in combination with Keytruda to slow or halt aggressive melanoma growth. (press release), and about 4 months into a similar Phase 3 trial of the same drug combo for small cell lung cancer (press release). Here’s hoping that 2025 is the year we cure (some kinds of) cancer!

  • will_a113OPEnglish
    4·
    4 days ago

    Yup. I linked both the original press release about melanoma as well as the one from October about the similar trial for lung cancer.